Astrana Health (NASDAQ: ASTH) director sells 20K shares back to company

Rhea-AI Filing Summary

Astrana Health, Inc. (ASTH) director David Schmidt reported a same-day option exercise and share disposition. He exercised 20,000 stock options for Common Stock at an exercise price of $5.00 per share, then disposed of 20,000 Common Shares to the issuer at $38.59 per share. The options were fully vested and exercisable, and following these transactions his holdings include 4,525 shares of restricted stock that vest on the earlier of June 10, 2027 or the 2027 annual meeting.

Insider Trade Summary

20,000 shares exercised/converted

Exercise 3 txns

Insider Schmidt David

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to Buy) F3	20,000	$0.00	$0.00
Exercise	Common Stock	20,000	$5.00	$100K
Disposition	Common Stock F1, F2	20,000	$38.59	$772K

Holdings After Transaction: Stock Option (right to Buy) — 0 shares (Direct); Common Stock — 36,019 shares (Direct)

Footnotes (3)

1. F1. These shares were repurchased by the Issuer.
2. F2. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.
3. F3. These stock options were fully vested and exercisable.

Key Figures

Options Exercised: 20,000 shares Option Exercise Price: $5.0000 per share Disposition Price to Issuer: $38.5900 per share +3 more

6 metrics

Options Exercised 20,000 shares Stock Option (right to Buy) for Common Stock exercised on 2026-08-14

Option Exercise Price $5.0000 per share Conversion or exercise price of stock options

Disposition Price to Issuer $38.5900 per share Price for 20,000 Common Shares disposed to issuer on 2026-08-14

Shares Disposed to Issuer 20,000 shares Common Stock disposition to issuer, coded as D

Restricted Stock 4,525 shares Restricted stock that will vest by June 10, 2027 or 2027 annual meeting

Option Expiration Date 2026-09-14 Expiration date of the exercised stock options

Key Terms

Stock Option (right to Buy), restricted stock, Disposition to issuer, fully vested and exercisable

4 terms

Stock Option (right to Buy) financial

"security_title: Stock Option (right to Buy)"

restricted stock financial

"Includes 4,525 shares of restricted stock, which will vest"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Disposition to issuer financial

"transaction_code_description: Disposition to issuer"

fully vested and exercisable financial

"These stock options were fully vested and exercisable."

FAQ

What insider transactions did ASTH director David Schmidt report on August 14, 2026?

On August 14, 2026, David Schmidt exercised 20,000 stock options for Astrana Health (ASTH) at $5.00 per share and then disposed of 20,000 Common Shares to the issuer at $38.59 per share in a same-day sequence.

At what prices were David Schmidt’s ASTH option exercise and share disposition executed?

David Schmidt exercised Astrana Health (ASTH) options at an exercise price of $5.00 per share and then disposed of the resulting 20,000 Common Shares to the issuer at $38.59 per share, according to the Form 4 filing.

How many Astrana Health (ASTH) options did David Schmidt exercise in this Form 4?

David Schmidt exercised 20,000 stock options for Astrana Health (ASTH) Common Stock. These options were fully vested and exercisable and carried an exercise price of $5.00 per share, expiring on September 14, 2026 if not exercised.

Did David Schmidt sell or return his ASTH shares to the issuer in this transaction?

Yes. After exercising 20,000 options, David Schmidt disposed of 20,000 Common Shares in a disposition to the issuer. A footnote specifies that these shares were repurchased by Astrana Health, at a reported price of $38.59 per share.

What restricted stock holdings does David Schmidt report after these ASTH transactions?

Following the reported transactions, David Schmidt’s holdings include 4,525 shares of restricted stock of Astrana Health (ASTH). These restricted shares will vest on the earlier of June 10, 2027 or the date of the company’s 2027 annual meeting.

Were David Schmidt’s ASTH stock options fully vested at the time of exercise?

Yes. A footnote states that the 20,000 stock options exercised by David Schmidt for Astrana Health (ASTH) were fully vested and exercisable at the time of the August 14, 2026 transaction, prior to their stated expiration on September 14, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/18/2026 - 04:16 PM Accepted by SEC EDGAR 08/18/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schmidt David

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVE, 2ND FLOOR

(Street)

ALHAMBRA CALIFORNIA 91801

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/14/2026		M		20,000	A	$5	56,019	D
Common Stock	08/14/2026		D(1)		20,000	D	$38.59	36,019(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to Buy)	$5	08/14/2026		M			20,000	(3)	09/14/2026	Common Stock	20,000	$0	0	D

Explanation of Responses:

1. These shares were repurchased by the Issuer.

2. Includes 4,525 shares of restricted stock, which will vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.

3. These stock options were fully vested and exercisable.

	/s/ Kathy Diep, as Attorney-in-Fact	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)